Clinical Trials Directory

Trials / Completed

CompletedNCT07492264

Evaluation of Food Supplementation in Subjects With Suboptimal Levels of LDL Cholesterol

Evaluation of the Effect of a Food Supplementation With a Combined Food Supplement in Healthy Subjects With Suboptimal LDL-C Levels: a Two-arm Double-blind, Placebo- Controlled, Randomized, Clinical Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Cooper Consumer Health · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This randomized, double-blind, placebo-controlled, parallel-group clinical study aims to evaluate the effect of a dietary supplement on LDL-cholesterol levels in healthy adults with suboptimal LDL-C values. Eligible participants will follow standard dietary recommendations based on the Mediterranean diet, according to the European Atherosclerosis Society guidelines. Subjects will be randomized to receive either the dietary supplement (1 tablet/day) or placebo (1 tablet/day), both in combination with dietary recommendations, over a treatment period of 12 weeks. The primary objective is to compare the effect of the tested food supplement versus placebo on LDL-cholesterol after 12 weeks of treatment. Secondary objectives include evaluating changes in LDL-cholesterol at 6 weeks, other lipid fractions, homocysteine, glucose and insulin levels, hsCRP, anthropometric parameters, as well as tolerability and acceptability of the supplement. Safety will be assessed through the collection of adverse events. Study participation lasts approximately 16 weeks, including screening, diet stabilization run-in, treatment, and follow-up assessments. Outcome measures will be collected at baseline, after 6 weeks, and after 12 weeks of treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNUT2Food supplement formulated with natural extracts
OTHERPlaceboPlacebo

Timeline

Start date
2020-02-21
Primary completion
2020-12-21
Completion
2020-12-21
First posted
2026-03-25
Last updated
2026-03-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07492264. Inclusion in this directory is not an endorsement.